FDA product code OQG: Hip Prosthesis, Semi-Constrained, Cemented, Metal/Polymer, + Additive, Porous, Uncemented

OQG is the FDA product code for hip prosthesis, semi-constrained, cemented, metal/polymer, + additive, porous, uncemented. It is a Class II device, regulated under 21 CFR 888.3358 and reviewed by the Orthopedic panel. FDA has cleared 20 510(k) submissions under OQG, from 14 different applicants. The average 510(k) review took 176 days (median 142). FDA has posted 2 recalls for OQG devices, 1 initiated in the last five years.

Definition

1. Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis. 2. Rheumatoid arthritis. 3. Correction of functional deformity. 4. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques. 5. Revision procedures where other treatment or devices have failed. Cemented and uncemented use.

Classification

FieldValue
Device nameHip Prosthesis, Semi-Constrained, Cemented, Metal/Polymer, + Additive, Porous, Uncemented
Device classClass II
Regulation21 CFR 888.3358
Review panelOR — Orthopedic
Medical specialtyOrthopedic
Premarket route510(k)
ImplantYes

510(k) clearances per year for OQG

YearClearancesAvg. review days
20173100
2020229
20212233

Compare with all 510(k) review times · Search every OQG clearance

Top OQG applicants

ApplicantClearancesLatest
Kyocera Medical Technologies, Inc.32021-04-02
Encore Medical L.P.32017-12-13
Total Joint Orthopedics, Inc.22017-10-27
Stelkast Company22012-10-09
Microport Orthopedics, Inc.12021-08-20

9 more applicants have OQG clearances. See the full list in Caduvo.

Most recent OQG clearances

510(k)ApplicantDeviceDecision dateReview days
K202705Microport Orthopedics, Inc.Prime and DYNASTY® Additive Manufacturing Shells2021-08-20338
K203472Kyocera Medical Technologies, Inc.KMTI Hip Replacement System2021-04-02128
K201660Kyocera Medical Technologies, Inc.KMTI Hip Replacement System, Tesera Trabecular Technologies (T3) Acetabular Shell System, Porous Acetabular Cup System2020-07-1628
K200328Kyocera Medical Technologies, Inc.Tesera Trabecular Technologies (T3) Acetabular Shell System, Porous Acetabular Cup System2020-03-1130
K172651Encore Medical L.P.FMP Extended Liners2017-12-1399

Recalls for OQG devices

2 product recalls in 2 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2023-06-16.

YearRecalls
20231

Frequently asked questions

What is FDA product code OQG?

OQG is the FDA product code for hip prosthesis, semi-constrained, cemented, metal/polymer, + additive, porous, uncemented. It is a Class II device, regulated under 21 CFR 888.3358 and reviewed by the Orthopedic panel.

What device class is OQG?

Class II, regulation 21 CFR 888.3358. Typical premarket route: 510(k).

How long does a 510(k) take for product code OQG?

Across 20 cleared submissions the average was 176 days from receipt to decision (median 142).

Which companies have the most OQG clearances?

Kyocera Medical Technologies, Inc. (3); Encore Medical L.P. (3); Total Joint Orthopedics, Inc. (2); Stelkast Company (2); Microport Orthopedics, Inc. (1).

Have OQG devices been recalled?

Yes: 2 product recalls across 2 recall events; the most recent began 2023-06-16.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Orthopedic product codes · FDA product code lookup · 510(k) database search · 510(k) review times